StonvexLoading…
StonvexStonvexStonvexCore line items from AMSF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $317.25M | $309.04M | $306.85M | $294.74M |
Operating Income | $58.85M | $69.06M | $77.38M | $67.65M |
Net Income | $47.15M | $55.44M | $62.11M | $55.60M |
EPS (Diluted) | $2.47 | $2.89 | $3.23 | $2.88 |
Total Assets | $1.13B | $1.16B | $1.23B | $1.27B |
Total Liabilities | $878.95M | $900.45M | $936.71M | $951.85M |
Cash & Equivalents | $61.93M | $44.05M | $38.68M | $61.47M |
Free Cash Flow OCF − CapEx | $8.92M | $23.35M | $29.29M | $26.11M |
Shares Outstanding | 18.79M | 19.05M | 19.14M | 19.16M |